DEI BioPharma
About Company
The DEI BioPharma Drugs and Vaccines Manufacturing Plant, which is located at Matugga in Wakiso District, was launched on July 6, 2021, by President Yoweri Museveni and then Kenyan Vice President (now President) William Ruto.
The facility, to cost USD 1 billion, seeks to produce high-quality yet affordable medicines, including those of cancer and malaria that will make a difference to millions of families across Africa.
This facility is the only African pharmaceutical company manufacturing the Covid-19 therapeutic medications and gearing to produce 1bn doses of mRNA vaccines guided by World Health Organization (WHO) standards.
At the launch, the two leaders expressed optimism that the construction of the facility, would concretise efforts to make Africa self-sustaining in healthcare.
Vice President (now President) Ruto said: “It is very reassuring that people of this continent and especially East Africans like Dr. Mathias Magoola are turning challenges into opportunities. With this facility, Africa will produce medicines to supply not only Africa but the globe. It’s gratifying that Africa can no longer be a source of problems but solutions.”
Dei Group Managing Director, Dr. Mathias Magoola secured more than 3,000 formulations, giving it a wide array of potential drugs for production, vaccines, anti-cancer drugs, therapeutic proteins, peptides and cell therapy, among others.
In March 2022, experts from the WHO commended Dei Biopharma for establishing the manufacturing facility, saying it provides a base for Africa to effectively respond to Covid-19 and other viruses.
What we believe in
Our Vision
- To create business opportunities and solutions for Africa through production of quality medicines using the latest innovative processes.
- To be the most preferred partner of choice of contract manufacturing and pharmaceutical branding
Our Mission
- We aspire to become a globally acclaimed pharmaceutical company that produces a diverse portfolio of vaccines and low cost drugs, which treat diseases that afflict most people. We also seek to empower Africa through innovation, research, manufacturing and technology.
- Innovation
- Quality
- Reliability
- Integrity
- Research and Development
- Customer Focus
- Collaboration
- Teamwork
Project Financing
The development of the facility has been financed through partner funding from the Equity Group and several other funders including the Uganda Development Bank (UDB), with funds being used for construction works, importation of Hi-Tech Medical Equipment and machines as well as working capital support.
